These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 16426913

  • 1. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr R.
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A.
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [Abstract] [Full Text] [Related]

  • 4. Molecular evidence supporting field effect in urothelial carcinogenesis.
    Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, Cocco A, Cheng L.
    Clin Cancer Res; 2005 Sep 15; 11(18):6512-9. PubMed ID: 16166427
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD, Carr MD, Eble JN, Wang M, Lopez-Beltran A, Cheng L.
    Cancer; 2005 Nov 01; 104(9):1901-10. PubMed ID: 16196038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
    Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A.
    Eur Urol; 2005 Jan 01; 47(1):58-63. PubMed ID: 15582250
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R, Utting M, Werner W, Schimmel B, Claussen U, Junker K.
    Int J Oncol; 2002 Jan 01; 20(1):107-15. PubMed ID: 11743649
    [Abstract] [Full Text] [Related]

  • 11. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.
    Hartmann A, Rösner U, Schlake G, Dietmaier W, Zaak D, Hofstaedter F, Knuechel R.
    Lab Invest; 2000 May 01; 80(5):709-18. PubMed ID: 10830781
    [Abstract] [Full Text] [Related]

  • 12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA.
    Cancer Res; 1996 Nov 01; 56(21):5039-43. PubMed ID: 8895761
    [Abstract] [Full Text] [Related]

  • 13. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG.
    Oncogene; 1999 Feb 04; 18(5):1185-96. PubMed ID: 10022124
    [Abstract] [Full Text] [Related]

  • 14. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
    Paterson RF, Ulbright TM, MacLennan GT, Zhang S, Pan CX, Sweeney CJ, Moore CR, Foster RS, Koch MO, Eble JN, Cheng L.
    Cancer; 2003 Nov 01; 98(9):1830-6. PubMed ID: 14584063
    [Abstract] [Full Text] [Related]

  • 15. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J, Saez MC, Sierra E, Torres A, Balibrea JL, Hernando F, Sanz-Esponera J, Merino MJ.
    J Pathol; 2001 Nov 01; 195(4):429-34. PubMed ID: 11745674
    [Abstract] [Full Text] [Related]

  • 16. Role of chromosome 9 in human bladder cancer.
    Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, Gonzalez-Zulueta M, Nichols PW, Skinner DG, Jones PA.
    Cancer Res; 1993 Sep 01; 53(17):4066-70. PubMed ID: 8358736
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS, Li L, Zhang RD, Kram A, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B.
    Oncogene; 2001 Aug 16; 20(36):5005-14. PubMed ID: 11526485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.